ANI Acquires Alimera Sciences To Bolster Ophthalmology Portfolio

The Move Reflects ANI’s Ambition To Increase Foothold In Rare Disease

 
• By Adam Zamecnik
Illustrative image of a deal
• Source: Shutterstock

More from Deals

More from Business